Valuation: Haleon plc

Capitalization 3.57TCr 4.87TCr 4.1TCr 3.73TCr 6.6TCr 4,41500Cr 6.89TCr 43TCr 17TCr 2,12700Cr 18TCr 18TCr 7,51700Cr P/E ratio 2025 *
22.7x
P/E ratio 2026 * 21.1x
Enterprise value 4.32TCr 5.9TCr 4.96TCr 4.52TCr 7.99TCr 5,34500Cr 8.35TCr 52TCr 21TCr 2,57500Cr 22TCr 22TCr 9,10200Cr EV / Sales 2025 *
3.9x
EV / Sales 2026 * 3.68x
Free-Float
89.25%
Yield 2025 *
1.77%
Yield 2026 * 1.98%
1 day+2.04%
1 week+4.63%
Current month+5.67%
1 month+8.95%
3 months+10.85%
6 months+12.73%
Current year+6.83%
1 week 380.8
Extreme 380.8
401.9
1 month 353.3
Extreme 353.3
401.9
Current year 353.3
Extreme 353.3
401.9
1 year 274.4
Extreme 274.4
419.5
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 22/07/2021
Director of Finance/CFO 56 01/11/2024
Chief Tech/Sci/R&D Officer 63 01/08/2025
Director TitleAgeSince
Director/Board Member 59 23/05/2022
Chairman 71 01/01/2026
Director/Board Member 59 18/07/2022
Change 5d. change 1-year change 3-years change Capi.($)
+2.04%+4.63%+5.54%+22.20% 4.78TCr
-1.88%-1.83%+16.70%+199.89% 94TCr
-0.12%+3.29%+55.66%+47.68% 57TCr
-0.37%-1.42%+16.71%+49.59% 39TCr
-0.76%-0.96%+21.49%+23.37% 37TCr
-0.42%+3.33%+34.22%+9.77% 29TCr
+1.99%+0.88%+22.10%+26.58% 29TCr
+0.67%+3.21%+24.96%+51.08% 30TCr
+1.27%-15.57%-49.92%-34.86% 22TCr
-2.97%+5.79%+24.22%+51.94% 20TCr
Average -0.05%+1.89%+17.17%+44.72% 36.28TCr
Weighted average by Cap. -0.50%+2.13%+22.12%+75.08%

Financials

2025 *2026 *
Net sales 1.11TCr 1.51TCr 1.27TCr 1.16TCr 2.05TCr 1,37100Cr 2.14TCr 13TCr 5.37TCr 66TCr 5.68TCr 5.56TCr 2,33500Cr 1.16TCr 1.58TCr 1.33TCr 1.21TCr 2.14TCr 1,43000Cr 2.23TCr 14TCr 5.6TCr 69TCr 5.92TCr 5.8TCr 2,43500Cr
Net income 158.74Cr 216.98Cr 182.33Cr 166.23Cr 293.72Cr 20TCr 306.85Cr 1.93TCr 768.82Cr 9.47TCr 813.88Cr 797.02Cr 33TCr 168.9Cr 230.87Cr 194Cr 176.87Cr 312.53Cr 21TCr 326.49Cr 2.05TCr 818.03Cr 10TCr 865.98Cr 848.04Cr 36TCr
Net Debt 751.72Cr 1.03TCr 863.42Cr 787.21Cr 1.39TCr 93TCr 1.45TCr 9.14TCr 3.64TCr 45TCr 3.85TCr 3.77TCr 1,58400Cr 687.29Cr 939.44Cr 789.41Cr 719.73Cr 1.27TCr 85TCr 1.33TCr 8.36TCr 3.33TCr 41TCr 3.52TCr 3.45TCr 1,44900Cr
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,561
Date Price Change Volume
10/26/10 400.40 p +2.04% 83,18,754
09/26/09 392.40 p -1.43% 1,61,92,310
06/26/06 398.10 p -0.30% 81,54,716
05/26/05 399.30 p +1.09% 2,11,41,110
04/26/04 395.00 p +2.76% 1,37,11,190
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
4.004GBP
Average target price
4.224GBP
Spread / Average Target
+5.50%

Quarterly revenue - Rate of surprise